HTB homepage • Conference reports • Articles by subject • Subscribe 30 October 2008 Contents Editorial Volume 9 Number 9/10 Sep/Oct 2008 Conference reports 17th International AIDS Conference, 3-8 August 2008, Mexico City Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease HAART use in pregnancy and preterm delivery and low birth weight Reasons for mother to child transmission in England New paediatric formulations of ARVs 3rd International Transmission Workshop, 1-2 August 2008, Mexico City Intermittent tenofovir/FTC PrEP offers monkeys some protection Tenofovir/FTC gel protects female monkeys from SHIV Recently infected HIV-positive Quebec residents cause more than half of new cases Common estimate of heterosexual HIV transmission risk sometimes far too low Antiretrovirals EMEA state that animal studies support no increased risk of malignancy from contamination of nelfinavir (Viracept) with ethyl mesilate (EMS) Antiretrovirals calculated to extend life expectancy by 35 years Etravirine approved in Europe Abacavir label updated in the US on use of B-5701 testing and cardiovascular risk Ritonavir label updated in the US relating to cardiac arrhythmia reported in high-dose studies Atazanavir label updated in the US relating to drug interactions with NNTRIs, hormonal contraceptives, midazolam, H2 receptor antagonists and other drugs Treatment access Brazil rejects Gilead patent on tenofovir PEPFAR bill may lift US HIV travel and residency ban Atripla to be licensed in Latin America and the Asia-Pacific region Pregnancy Tenofovir safe in pregnancy in macaque model PK and drug interactions Drug interaction reports from Liverpool University website Guidelines UK National Guidelines for HIV Testing 2008 UK Guidelines on the Management of HIV infection in Pregnant Women (2008) published UK Guidelines on HIV Associated Malignancies (2008) published online US paediatric guidelines updated (2008) HIV prevention and transmission Implications of transmission with undetectable HIV viral load: lower limit for HIV transmission excluded from model Case report of sexual transmission when viral load suppressed to <50 copies/mL HIV RNA is detectable in semen in 5% patients with undetectable blood plasma viral attending fertility clinic Tenofovir gel as a rectal microbicide: evidence for protection and priming of T-cell responses in the SIV challenge model Genetic protection against malaria may increase susceptibility to HIV infection in people of African decent US CDC issue reports of false-positive oral rapid tests in New York HIV testing programme Basic science and immunology US cancel phase 3 HIV vaccine trial Microbial translocation in immunological non-responders to ART Other news Detained Chinese AIDS activist quietly sentenced during Olympics Free The Iranian HIV/AIDS Doctors! Opportunity for doctor to work in Thailand Ugandan activists acquitted of trespass charges after objecting to exclusion of sexual minorities from the national HIV/AIDS programme HTB homepage • Conference reports • Articles by subject • Subscribe
